<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antigens of <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> are the same for <z:hpo ids='HP_0000001'>all</z:hpo> the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> due to the same virus </plain></SENT>
<SENT sid="1" pm="."><plain>Antibodies in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> bearing animals allow to detect antigens in nucleus, in cytoplasm and on the cell membrane which carries also embryonic antigens and the antigen responsible for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> rejection by sensitized lymphcytes (TSTA or TATA) </plain></SENT>
<SENT sid="2" pm="?"><plain>Is this antigen identical to the surface antigen shown by antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>Purification of membrane antigens will answer this important question </plain></SENT>
<SENT sid="4" pm="."><plain>Chemically induced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> bear <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> rejection antigens having an individual specificity, perhaps related to modified histocompatibility antigens, and embryonic antigens </plain></SENT>
<SENT sid="5" pm="."><plain>Both give rise to antibodies and sensitized lymphocytes </plain></SENT>
<SENT sid="6" pm="."><plain>Among human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is strongly antigenic </plain></SENT>
<SENT sid="7" pm="."><plain>Its <z:mp ids='MP_0001799'>viral</z:mp> origin is highly likely </plain></SENT>
<SENT sid="8" pm="."><plain>Antibodies in sera of Burkitt patients react with antigens present in nucleus, cytoplasm and on the membrane of malignant or transformed cells </plain></SENT>
<SENT sid="9" pm="."><plain>Sensitized lymphocytes in the peripheral blood recognize a membrane antigen probably different of that revealed by antibodies </plain></SENT>
<SENT sid="10" pm="."><plain>Antibodies found in sera of patients with <z:mp ids='MP_0002038'>carcinoma</z:mp> react mainly with tissular antigens </plain></SENT>
<SENT sid="11" pm="."><plain>In these cases, methods exploring delayed type reactivity, such as leukocyte migration inhibition and moreover skin testing with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> extracts, gave some promising results </plain></SENT>
</text></document>